Company Registration No. SC620800 (Scotland)
HYLOMORPH SOLUTIONS LIMITED
Annual Report and Statement of Accounts
For the Period from 01 March 2022 to 28 February 2023

HYLOMORPH SOLUTIONS LIMITED

Annual report and statement of accounts for the period ending 28/02/2023

HYLOMORPH SOLUTIONS LIMITED

Financial statement for the period ended 28/02/2023

Company Information

1 Statutory Information
Company Number SC620800
Registered Office 272 BATH STREET
GLASGOW
G2 4JR
2 Directors
Directors who held office during the period were:
Kevin HAMMOND   
KRAWIEC, Krzysztof, Professor   
SWAN, Caroline, Dr   
3 Principal Activity
Software Consultancy and Product Development
4 Employees
Average number of employees, including directors, during the year was as follows:
2023 3
2022 3

HYLOMORPH SOLUTIONS LIMITED

Financial statement for the period ended 28/02/2023

Statement of Financial Position

2023 2022
£ £
Fixed Assets 8,590 4,560
Current Assets 150,828 93,068
Prepayment and accrued Income 41,665 -
Creditors: amounts falling due within one year (15,000) (15,000)
Net Current Assets 177,493 78,068
Total assets less current liabilities 186,083 82,628
Creditors: amounts falling due after one year - -
Provisions for liabilities (10,992) (11,634)
Net Assets 175,091 70,994
Capital and reserves 175,091 70,994
For the period ending 28/02/2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Approved by the Board on 15 August 2023
Kevin Hammond
Company Registration No. SC620800